Search
Enter keywords, a title or a report id number below.
Your Search for 'Proteomic and Genomic Analysis of Cardiovascular Disease' returned 17 results - Page 1 of 1
Sort by
Sorted by
Rank
Top-Bottom
-
Proteomics - Technologies, Markets and Companies
Jain PharmaBiotech, May 2013 , Pages: 631of medicine in the post-genomic era - the first decade of the 21st century. Most commonly used technologies are 2D gel electrophoresis for protein separation and analysis of proteins by mass ... -
Biomarkers - Technologies, Markets and Companies
Jain PharmaBiotech, May 2013 , Pages: 920Peptides in body fluids and tissues as biomarkers of disease Analysis of peptides in bodily fluids Serum peptidome patterns SISCAPA method for quantitating proteins and peptides in plasma Comparison of ... -
Personalized Medicine - Scientific and Commercial Aspects
Jain PharmaBiotech, May 2013 , Pages: 854diagnosis Proteomic strategies for biomarker identification Proteomic technologies for detection of biomarkers in body fluids Protein patterns Layered Gene Scanning Comparison of proteomic and genomic ... -
The Convergence of Biomarkers and Diagnostics: Therapy area analyses, key products and future trends
Scripp Business Insights, Apr 2008 , Pages: 265acceptance of biomarkers Prospects for companion diagnostics Biomarkers patent survey Chapter 8 Appendix Research Methodology Proteomic Cancer Biomarkers Biomarkers of Cardiovascular Disease and Stroke ... -
Therapeutic Drug Monitoring - Technologies, Markets, and Companies
Jain PharmaBiotech, May 2013 , Pages: 169drug safety studies Genomic technologies for toxicology biomarkers Proteomic technologies for toxicology biomarkers Metabonomic technologies for toxicology biomarkers Integration of genomic and ... -
Cytogenetics - Technologies, Markets and Companies
Jain PharmaBiotech, May 2013 , Pages: 231expression array and direct molecular analysis without amplification. Analysis of single-cell gene expression promises a more precise understanding of human disease pathogenesis and has important diagnostic ... -
Molecular Diagnostics - Technologies, Markets and Companies
Jain PharmaBiotech, May 2013 , Pages: 1090Prostate cancer Early detection of prostate cancer recurrence by nanotechnology Gene expression analysis of prostate cancer Huntingtin Interacting Protein 1 Integrative genomic and proteomic profiling of ... -
Cell Therapy - Technologies, Markets and Companies
Jain PharmaBiotech, May 2013 , Pages: 1050cells Cloned cells for transplantation medicine Claims of cloning of hESCs Cytogenetics of embryonic stem cells Stem cell proteomics Comparative proteomic analysis of somatic cells, iPSCs and ESCs ... -
Animal Biotechnology - Technologies, Markets and Companies
Jain PharmaBiotech, May 2013 , Pages: 370Genomics of disease resistance Genome wide associations and milk production in cows Low cost genotyping for genetic improvement in dairy cattle SNPs and longevity in dairy cattle Share genomic data to ... -
Biomarker Technology Platforms for Cancer Diagnoses and Therapies
TriMark Publications, Sep 2011 , Pages: 343Design 2.6.6 Exploiting the Power of MS to Improve Assay Specificity 2.6.7 Creating and Maintaining a Multi-Disease Product Pipeline 2.6.8 Partnerships for Developing Proteomic Biomarkers 2.7 Epigenic ... -
Outlook of China Genomics and Proteomics Market - Application in Molecular Biomarker, Diagnostics and Personalized Medicine
JZMed Inc, Jan 2011 , Pages: 282, product development capabilities in biomarkers and diagnostics, and portfolio distributions of genomic, proteomic and diagnostic products. With detailed analysis of the current market size of the Chinese ... -
Biomarkers - Global Strategic Business Report
Global Industry Analysts, Inc, Aug 2011 , Pages: 1305Myoglobin 53 New Diagnostic Biomarkers for ACS on the Anvil 54 Genomic Biomarkers for Detecting Cardiovascular Diseases 54 Growing Demand for Stroke Biomarkers 55 Rising Incidence of the Disease - A Major ... -
Pharmacogenomics for Clinical Use and in Drug Development
TriMark Publications, Jun 2009 , Pages: 244Serotonin Re-uptake Inhibitors 111 4.3.4.3 Mirtazapine and Venlafaxine 111 4.3.4.4 Nefazodone, Moclobemide, Reboxetine and Trazodone 111 4.3.5 Pharmacogenomics of Cardiovascular Disease 112 4.3.5.1 Beta ... -
Heart Development and Regeneration
Elsevier Science and Technology, May 2010 , Pages: 1136Cardiovascular Development and Disease 2.3 MicroRNA Regulation of Cardiac Development and Disease 3.1 Genomic Analysis in the Developing and Diseased Heart 3.2 Exploring Congenital Cardiovascular ... -
Molecular Diagnostics - Global Strategic Business Report
Global Industry Analysts, Inc, Nov 2012 , Pages: 572screening testing, food pathogen testing, cardiovascular disease testing, tissue typing testing and oncology testing to name a few. Almost all of donated blood is currently screened using molecular methods ... -
Proteomics: Promising Research, Potential Applications, And New Developments (Technical Insights)
Frost & Sullivan, Oct 2001Disease 3. Genicon Sciences: Measuring Minute Protein Levels 4. With IBM: Genomics Knowledge Platform Allows Integration of Genomic; Proteomic Data 5. With Galapagos: Overexpression of Human Genes in ... -
Biochips - Products, Applications, Technologies and End-Use Markets Growth Analysis, 2009-2015
Axis Research Mind, Feb 2011 , Pages: 599Biochips - Products, Applications, Technologies and End-Use Markets Growth Analysis, 2009-2015 Global Market Watch: Global biochips market is forecasted to reach US$9.1 billion by 2015 with a CAGR of ...
Results:
First - Prev -
1 -
Next - Last
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network